Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
暂无分享,去创建一个
A. McNulty | J. Hocking | P. Timms | L. Vodstrcil | C. Fairley | W. Huston | Bryan A. Wee | B. Donovan | Marcus Y. Chen | S. Phillips | K. Worthington | Amba Lawrence | Mark Thomas | Ruthy McIvor
[1] N. Woodford,et al. Whole-genome sequencing of Chlamydia trachomatis isolates from persistently infected patients , 2022, International journal of STD & AIDS.
[2] K. Shima,et al. Impact of First-Line Antimicrobials on Chlamydia trachomatis-Induced Changes in Host Metabolism and Cytokine Production , 2021, Frontiers in Microbiology.
[3] A. McNulty,et al. Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis. , 2021, The New England journal of medicine.
[4] Lijun Huang,et al. Insights Into Host Cell Cytokines in Chlamydia Infection , 2021, Frontiers in Immunology.
[5] H. Kitaura,et al. Inhibition of the CXCL9-CXCR3 axis suppresses the progression of experimental apical periodontitis by blocking macrophage migration and activation , 2021, Scientific Reports.
[6] S. Lemon,et al. Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses , 2021, PLoS pathogens.
[7] J. Hocking,et al. A retrospective cohort study examining STI testing and perinatal records demonstrates reproductive health burden of chlamydia and gonorrhea. , 2020, Pathogens and disease.
[8] Yong Jiang,et al. High treatment failure rate is better explained by resistant gene detection than by minimal inhibitory concentrations in patients with urogenital Chlamydia trachomatis infection. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[9] S. Pullon,et al. Chlamydia trachomatis and Neisseria gonorrhoeae retesting and reinfection rates in New Zealand healthcare settings: implications for STI control. , 2019, Sexually transmitted diseases.
[10] P. Gajer,et al. Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection , 2019, The Journal of infectious diseases.
[11] C. Hoebe,et al. Viable bacterial load is key to azithromycin treatment failure in rectally Chlamydia trachomatis infected women (FemCure). , 2019, The Journal of infectious diseases.
[12] G. Veres,et al. Indoleamine 2,3-Dioxygenase Activity in Chlamydia muridarum and Chlamydia pneumoniae Infected Mouse Lung Tissues , 2019, Front. Cell. Infect. Microbiol..
[13] R. Carabeo,et al. Author response: A bipartite iron-dependent transcriptional regulation of the tryptophan salvage pathway in Chlamydia trachomatis , 2019 .
[14] Xiaofei Chi,et al. An Adaptive Chlamydia trachomatis-Specific IFN-γ-Producing CD4+ T Cell Response Is Associated With Protection Against Chlamydia Reinfection in Women , 2018, Front. Immunol..
[15] W. Geisler,et al. HLA-DQB1*06 is a risk marker for chlamydia reinfection in African American women , 2018, Genes & Immunity.
[16] Andrew J. Olive,et al. Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populations , 2018, Proceedings of the National Academy of Sciences.
[17] Bette C Liu,et al. Risk of Pelvic Inflammatory Disease in Relation to Chlamydia and Gonorrhea Testing, Repeat Testing, and Positivity: A Population-Based Cohort Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] C. Dinarello. Overview of the IL‐1 family in innate inflammation and acquired immunity , 2018, Immunological reviews.
[19] E. Faragher,et al. Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection – a double blind, randomised controlled trial in Burkina Faso , 2017, BMC Medicine.
[20] J. Ravel,et al. Does Active Oral Sex Contribute to Female Infertility? , 2017, The Journal of infectious diseases.
[21] P. Timms,et al. In vitro rescue of genital strains of Chlamydia trachomatis from interferon-γ and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp. , 2016, BMC Microbiology.
[22] M. Currie,et al. Rectal chlamydia infection in women at high risk of chlamydia attending Canberra Sexual Health Centre , 2016, International journal of STD & AIDS.
[23] M. Price,et al. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. , 2016, Health technology assessment.
[24] C. Hoebe,et al. What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion , 2015, BMC Infectious Diseases.
[25] J. Hocking,et al. Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women , 2015, Clinical Microbiology Reviews.
[26] J. Hocking,et al. The Epidemiology of Chlamydia trachomatis Organism Load During Genital Infection: A Systematic Review. , 2015, The Journal of infectious diseases.
[27] M. Tan,et al. The transcriptional repressor EUO regulates both subsets of Chlamydia late genes , 2014, Molecular microbiology.
[28] Torsten Seemann,et al. Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..
[29] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[30] Barry G. Hall,et al. When Whole-Genome Alignments Just Won't Work: kSNP v2 Software for Alignment-Free SNP Discovery and Phylogenetics of Hundreds of Microbial Genomes , 2013, PloS one.
[31] W. Huston,et al. The IL-6 response to Chlamydia from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infection , 2013, BMC Immunology.
[32] J. Hocking,et al. A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol , 2013, BMC Infectious Diseases.
[33] M. Bogyo,et al. Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis , 2013, Molecular microbiology.
[34] D. De Angelis,et al. Risk of Pelvic Inflammatory Disease Following Chlamydia trachomatis Infection: Analysis of Prospective Studies With a Multistate Model , 2013, American journal of epidemiology.
[35] R. DiClemente,et al. Improving the validity of self-reported sexual behavior: no easy answers. , 2013, Sexually transmitted diseases.
[36] M. El-Bahrawy,et al. The expression of interleukin (IL)-6, IL-8, and their receptors in fallopian tubes with ectopic tubal gestation. , 2012, Fertility and sterility.
[37] M. Harigopal,et al. Comparing two methods of detection for Chlamydia trachomatis in liquid-based Papanicolaou tests. , 2012, American journal of clinical pathology.
[38] Samuel A. Assefa,et al. A post-assembly genome-improvement toolkit (PAGIT) to obtain annotated genomes from contigs , 2012, Nature Protocols.
[39] M. Tan,et al. Differential Effects of DNA Supercoiling on Chlamydia Early Promoters Correlate with Expression Patterns in Midcycle , 2012, Journal of bacteriology.
[40] N. Welton,et al. Multi‐Parameter Evidence Synthesis , 2012 .
[41] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[42] S. Singh,et al. The Anti-Inflammatory Cytokine, Interleukin-10, Inhibits Inflammatory Mediators in Human Epithelial Cells and Mouse Macrophages Exposed to Live and UV-Inactivated Chlamydia trachomatis , 2012, Mediators of inflammation.
[43] P. Timms,et al. Unique Residues Involved in Activation of the Multitasking Protease/Chaperone HtrA from Chlamydia trachomatis , 2011, PloS one.
[44] S. Garland,et al. Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia , 2011, BMC public health.
[45] Steven Salzberg,et al. Mugsy: fast multiple alignment of closely related whole genomes , 2010, Bioinform..
[46] N. Lycke,et al. The Female Lower Genital Tract Is a Privileged Compartment with IL-10 Producing Dendritic Cells and Poor Th1 Immunity following Chlamydia trachomatis Infection , 2010, PLoS pathogens.
[47] D. Rockey,et al. Antibiotic resistance in Chlamydiae. , 2010, Future microbiology.
[48] D. Hafler,et al. FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.
[49] P. Wyrick. Chlamydia trachomatis persistence in vitro: an overview. , 2010, The Journal of infectious diseases.
[50] S. Garland,et al. Development and Evaluation of an ompA Quantitative Real-Time PCR Assay for Chlamydia trachomatis Serovar Determination , 2010, Journal of Clinical Microbiology.
[51] G. Zhong,et al. Identification of Chlamydia trachomatis Outer Membrane Complex Proteins by Differential Proteomics , 2010, Journal of bacteriology.
[52] Y. Bashmakov,et al. Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin , 2010, Comparative hepatology.
[53] J. Fortenberry,et al. Repeated Chlamydia trachomatis genital infections in adolescent women. , 2010, The Journal of infectious diseases.
[54] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[55] Michael Brudno,et al. SHRiMP: Accurate Mapping of Short Color-space Reads , 2009, PLoS Comput. Biol..
[56] P. Timms,et al. Chlamydia trachomatis responds to heat shock, penicillin induced persistence, and IFN-gamma persistence by altering levels of the extracytoplasmic stress response protease HtrA , 2008, BMC Microbiology.
[57] I. Daud,et al. Validation of Reference Genes in Cervical Cell Samples from Human Papillomavirus-Infected and -Uninfected Women for Quantitative Reverse Transcription-PCR Assays , 2008, Clinical and Vaccine Immunology.
[58] E. Birney,et al. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.
[59] A. Maurelli,et al. Frequency of Development and Associated Physiological Cost of Azithromycin Resistance in Chlamydia psittaci 6BC and C. trachomatis L2 , 2007, Antimicrobial Agents and Chemotherapy.
[60] Jonathan M. Harris,et al. The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 °C , 2007 .
[61] Jonathan M. Harris,et al. The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 degrees C. , 2007, FEBS letters.
[62] P. Mahadevan,et al. An overview , 2007, Journal of Biosciences.
[63] P. Horner,et al. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection , 2006, Sexually Transmitted Infections.
[64] M. Lehtinen,et al. IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis , 2006, Genes and Immunity.
[65] R. Peeling,et al. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. , 2005, The Journal of infectious diseases.
[66] K. Holmes,et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. , 2005, The New England journal of medicine.
[67] D. Metzger,et al. Azithromycin modulates murine immune responses to pneumococcal conjugate vaccine and inhibits nasal clearance of bacteria. , 2004, The Journal of infectious diseases.
[68] P. Timms,et al. Chlamydial Persistence: beyond the Biphasic Paradigm , 2004, Infection and Immunity.
[69] D. Virok,et al. Transcriptome analysis of chlamydial growth during IFN-γ-mediated persistence and reactivation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] G. Zhong,et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[71] W. Stamm,et al. Methodologies and Cell Lines Used for Antimicrobial Susceptibility Testing of Chlamydia spp , 2003, Antimicrobial Agents and Chemotherapy.
[72] D. Dean,et al. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. , 2000, The Journal of infectious diseases.
[73] Angela F. Harper,et al. Chlamydial Development Is Adversely Affected by Minor Changes in Amino Acid Supply, Blood Plasma Amino Acid Levels, and Glucose Deprivation , 2000, Infection and Immunity.
[74] W. Beatty,et al. Reactivation of persistent Chlamydia trachomatis infection in cell culture , 1995, Infection and immunity.
[75] W. Beatty,et al. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence , 1994, Infection and immunity.
[76] D. N. Carss,et al. Meeting report , 1975, Appetite.